Novel research has shown that women are frequently denied MRI scans, despite usual recommendations. Read more.
Man of Many US on MSN1d
Feel-Good Friday: 10 January – Shot Takers and Spritz MakersIt has been a long, hard first week back in the office, but there is light at the end of the tunnel. Friday has finally ...
A groundbreaking study led by the Mayo Clinic Comprehensive Cancer Center has significantly deepened our understanding of ...
"I just wish someone had told me this was a possibility." Kara Maxwell distinctly remembers the moment she heard those words ...
The National Institute for Health and Care Excellence (NICE) has given a positive recommendation for Lynparza (olaparib) for ...
The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend that the targeted drug olaparib can be used for locally advanced or metastatic breast cancer.
Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center have significantly advanced the understanding of genetic alterations in the ...
Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.
2d
Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center ...
Testing BRCA2 has long been a staple of hereditary cancer testing, as pathogenic variants in the gene are associated with cancers of the breast, ovary, prostate, and pancreas. 2-5 Despite the ...
"Inside Edition" correspondent Alison Hall opens up about her breast cancer battle and how Olivia Munn's own experience with early detection inspired her to take a life-saving risk assessment test.
Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback